Amgen Inc. (AMGN) Free cash flow 2016–2025
Amgen Inc. (AMGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$8.1BFY2025 · since FY2016: $9.6B → $8.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.1B | -22.1% |
| FY2024 | $10.4B | +41.2% |
| FY2023 | $7.4B | -16.2% |
| FY2022 | $8.8B | +4.8% |
| FY2021 | $8.4B | -15.2% |
| FY2020 | $9.9B | +15.9% |
| FY2019 | $8.5B | -19.2% |
| FY2018 | $10.6B | +0.4% |
| FY2017 | $10.5B | +9.3% |
| FY2016 | $9.6B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AMGN financial trends
AMGN RevenueAMGN Net incomeAMGN Net marginAMGN Gross profitAMGN Gross marginAMGN Operating incomeAMGN Operating marginAMGN Operating cash flowAMGN Capital expendituresAMGN Return on equityAMGN Stock buybacksAMGN Dividends paidAMGN Total assetsAMGN Total liabilitiesAMGN Shareholders’ equityAMGN overview →